근감소증의 진단과 신경학적 견해
Diagnosis and Neurological View of Sarcopenia
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Sarcopenia (Greek ‘sarx’ or flesh+‘penia’ or loss) originally is proposed as the term to describe age-related decrease of muscle mass. These days, sarcopenia is defined as a syndrome characterized by progressive loss of skeletal muscle mass and strength with a risk of adverse outcomes such as poor quality of life, physical disability, and death. In the recent decade, there are a few of consensus; European, international, and Asian consensus panels have published definitions. Additionally, measurement techniques that can be used for research and clinical practice settings according to their suitability are suggested. Many studies are reported about the association with sarcopenia and neurologic diseases, however, the results are heterogenous due to lack of sufficient studies. Some pharmacologic and non-pharmacologic methods are suggested as the intervention of sarcopenia, although there are not enough studies, yet. In this review, we summarize current understanding of the diagnostic sarcopenia and neurological point of view of sarcopenia.
Abstract
Sarcopenia (Greek ‘sarx’ or flesh+‘penia’ or loss) originally is proposed as the term to describe age-related decrease of muscle mass. These days, sarcopenia is defined as a syndrome characterized by progressive loss of skeletal muscle mass and strength with a risk of adverse outcomes such as poor quality of life, physical disability, and death. In the recent decade, there are a few of consensus; European, international, and Asian consensus panels have published definitions. Additionally, measurement techniques that can be used for research and clinical practice settings according to their suitability are suggested. Many studies are reported about the association with sarcopenia and neurologic diseases, however, the results are heterogenous due to lack of sufficient studies. Some pharmacologic and non-pharmacologic methods are suggested as the intervention of sarcopenia, although there are not enough studies, yet. In this review, we summarize current understanding of the diagnostic sarcopenia and neurological point of view of sarcopenia.
참고문헌 (16)
- Cruz-Jentoft AJ, "Sarcopenia: European consensus on definition and diagnosis:Report of the european working group on sarcopenia in older people", Age Ageing, 39, pp.412~423 (2010)
- Morley JE, "Sarcopenia with limited mobility: an international consensus", J Am Med Dir Assoc, 12, pp.403~409 (2011)
- Fielding RA, "Sarcopenia: an undiagnosed condition in older adults. current consensus definition: prevalence, etiology, and consequences. international working group on sarcopenia", J Am Med Dir Assoc, 12, pp.249~256 (2011)
- Chen LK, "Sarcopenia in asia: consensus report of the asian working group for sarcopenia", J Am Med Dir Assoc, 15, pp.95~101 (2014)
- McLean RR, "Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the national institutes of health (FNIH) sarcopenia project", J Gerontol A Biol Sci Med Sci, 69, pp.576~583 (2014)
- Chien MY, "Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in taiwan", J Am Geriatr Soc, 56, pp.1710~1715 (2008)
- Janssen I, "Estimation of skeletal muscle mass by bioelectrical impedance analysis", J Appl Physiol, 89, pp.465~471 (2000)
- Rolland Y, "Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study", J Am Geriatr Soc, 51, pp.1120~1124 (2003)
- Roberts HC, "A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach", Age Ageing, 40, pp.423~429 (2011)
- Nourhashemi F, "Is there a relationship between fat-free soft tissue mass and low cognitive function? results from a study of 7,105women", J Am Geriatr Soc, 50, pp.1796~1801 (2002)
- van Kan GA, "Association of a 7-year percent change in fat mass and muscle mass with subsequent cognitive dysfunction: the EPIDOS-toulouse cohort", J Cachexia Sarcopenia Muscle, 4, pp.225~229 (2013)
- Fritz NE, "Handgrip strength as a means of monitoring progression of cognitive decline - A scoping review", Ageing Res Rev, 35, pp.112~123 (2017)
- Scherbakov N, "Stroke-related sarcopenia: specific characteristics", J Am Med Dir Assoc, 16, pp.272~276 (2015)
- Minn YK, "Higher skeletal muscle mass may protect against ischemic stroke in community-dwelling adults without stroke and dementia:the PRESENT project", BMC Geriatr, 17, pp.45~ (2017)
- Kilgour AH, "A systematic review of the evidence that brain structure is related to muscle structure and their relationship to brain and muscle function in humans over the lifecourse", BMC Geriatr, 14, pp.85~ (2014)
- Lang T, "Sarcopenia: etiology, clinical consequences, intervention, and assessment", Osteoporos Int, pp.21543~21559 (2010)